Dr. Roxana Mehran is professor of medicine, and health policy, director of interventional cardiovascular research and clinical trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine. Dr. Mehran completed her training in internal medicine at the University of Connecticut, where she was also the chief medical resident, before continuing with fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center in New York. Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses. She has developed several risk scores for bleeding and acute kidney injury to identify patients at risk for these complications. Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, outcomes research, as well as advancing pharmacologic and interventional treatments for acute coronary syndromes and acute myocardial infarction. In addition to founding a highly regarded academic research organization at the Cardiovascular Research Foundation, where she has served as the chief scientific officer for the past 12 years, she is a widely published author and frequent invited speaker at national and international scientific conferences. Dr. Mehran is a member of the editorial board of multiple peer reviewed journals, including Journal of the American College of Cardiology, Circulation, Circulation Research, and Catheterization and Cardiovascular Interventions. She is currently a member of the board of directors for Harboring Hearts, and the program chair for Society of Cardiac Angiography and Interventions (SCAI- WIN (Women in Innovations)) Initiative.